MANE · Insider Trading
Veradermics, Incorporated
Every open-market purchase and sale reported by MANE officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | David Hollander | Chief R&D Officer | A | +9,650 | — |
| 2026-08-21 | Aaron Cowen | — | MIXED | −1,800,000 | −$321.75M |
| 2026-08-18 | Timothy August Durso | Chief Technical Officer | MIXED | −40,048 | −$4.65M |
| 2026-08-18 | Reid Alexander Waldman | Chief Executive Officer | MIXED | −64,048 | −$7.24M |
| 2026-08-14 | John W Childs | Director | Sell | −100,000 | −$10.71M |
| 2026-05-05 | Averill Master Fund, Ltd. | Director | A | +1,200,000 deriv. | — |
| 2026-02-27 | John W Childs | Director | Buy | +294,117 | +$5.00M |
| 2026-02-09 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | +1,130,696 | +$42.17M |
| 2026-02-05 | Michael V. Greco | General Counsel | A | +144,401 deriv. | — |
| 2026-02-05 | David Matthew Friedman | Director | A | +43,000 deriv. | — |
| 2026-02-05 | Dominic Gabriel Carrano | Chief Financial Officer | A | +148,011 deriv. | — |
| 2026-02-05 | Katarina Pance | Director | A | +43,000 deriv. | — |
| 2026-02-05 | Jane M. Grant-Kels | Director | C | +2,455 | — |
| 2026-02-05 | Patrick G Enright | Director | MIXED | +4,653,873 | +$18.27M |
| 2026-02-05 | Timothy August Durso | Chief Technical Officer | C | +1,473 | — |
| 2026-02-05 | Reid Alexander Waldman | Chief Executive Officer | C | +1,437 | — |
| 2026-02-05 | John W Childs | Director | MIXED | +2,202,006 | +$5.00M |
| 2026-02-05 | Mark Neumann | Chief Commercial Officer | A | +102,885 deriv. | — |
| 2026-02-05 | Vlad Coric | Director | MIXED | +755,908 | +$2.00M |
| 2026-02-05 | Longitude Capital Partners V, LLC | 10%+ Owner | MIXED | +18,615,492 | +$73.10M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | Director | 3,525,462 | $431.09M |
| Patrick G Enright | Director | 2,407,752 | $294.42M |
| Longitude Capital Partners V, LLC | 10%+ Owner | 2,407,752 | $294.42M |
| John W Childs | Director | 1,907,889 | $233.30M |
| Aaron Cowen | — | 612,033 | $74.84M |
| Vlad Coric | Director | 390,514 | $47.75M |
| Timothy August Durso | Chief Technical Officer | 194,859 | $23.83M |
| Reid Alexander Waldman | Chief Executive Officer | 170,824 | $20.89M |
| David Hollander | Chief R&D Officer | 9,650 | $1.18M |
| Jane M. Grant-Kels | Director | 2,455 | $300.20K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MANE quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.